πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 11 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10259780

Treatment of cataplexy

Jazz Pharmaceuticals International III Limited Β· Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10195151

Formulations of (R)-2-amino-3-phenylpropyl carbamate

Jazz Pharmaceuticals International III Limited Β· Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10105341

Treatment for obesity

Jazz Pharmaceuticals International III Limited Β· Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9707270

Method for administering Ο‰-conopeptide

Jazz Pharmaceuticals International III Limited Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9649291

Treatment for obesity

Jazz Pharmaceuticals International III Limited Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9585863

Treatment of cataplexy

Jazz Pharmaceuticals International III Limited Β· Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9359290

Treatment of cataplexy

Jazz Pharmaceuticals International III Limited Β· Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9226910

Treatment for obesity

Jazz Pharmaceuticals International III Limited Β· Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765680

Method for administering omega-conopeptide

Jazz Pharmaceuticals International III Limited Β· Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8653033

Method for administering omega-conopeptide

Jazz Pharmaceuticals International III Limited Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8513198

Pharmaceutical formulation for reducing pain

Jazz Pharmaceuticals International III Limited Β· Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted